As a master transcriptional regulator of lipid metabolism and cholesterol biosynthesis, SREBF1 may be modulated through obesity-altered metabolic pathways, potentially mediating weight-dependent cancer progression. Here, SREBF1 is linked to obesity due to melanocortin 4 receptor deficiency.